Cost-competitive North American capacity with FDA-export reach. Compare Health-Canada-regulated Canadian CDMOs across biologics, drug product, and analytical services — by capability and site.
Canada offers competitive North American manufacturing with a distinct cost advantage, supported by federal SR&ED tax credits and provincial incentives. Its CDMO base spans biologics, drug product, and analytical services, with clusters in Montreal, Toronto, and Vancouver.
Canadian facilities are regulated by Health Canada, which maintains mutual recognition agreements with the FDA, EMA, and other authorities — many Canadian CDMOs hold FDA registration for US-market products. For US sponsors, Canada combines near-shore proximity and time-zone alignment with lower costs.
Canada is a strong fit for sponsors who want North American manufacturing and FDA-export reach without full US pricing, particularly for clinical-stage biologics, drug product, and analytical work where the cost differential is meaningful.
No companies found in this category yet. Check back soon.
Browse all CDMOsHow this list is built: companies appear here when they have a manufacturing site in Canada in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Our AI Matchmaker analyzes your project requirements and matches you with qualified Canada manufacturing partners. Free for buyers.